Intuitive Surgical, Inc. $ISRG Stock Bought by Vestor Capital LLC

Key Points

• Vestor Capital increased its Intuitive Surgical stake by 299.1% in the third quarter, ending the period with 46,043 shares valued at about $18.7 million. Institutional investors collectively own 83.64% of the company’s stock.
• Intuitive Surgical reported quarterly earnings of $3.00 per share, beating the $2.65 consensus, while revenue of $3.05 billion rose 21.7% year over year and also exceeded estimates.
• Analysts’ consensus rating is Moderate Buy, with an average price target of $493.54. Company insiders sold 39,056 shares worth about $17.6 million over the prior quarter.

Vestor Capital LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 299.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 46,043 shares of the medical equipment provider's stock after purchasing an additional 34,507 shares during the period. Vestor Capital LLC's holdings in Intuitive Surgical were worth $18,722,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in the stock. Kestra Investment Management LLC boosted its holdings in Intuitive Surgical by 5.6% in the 3rd quarter. Kestra Investment Management LLC now owns 645 shares of the medical equipment provider's stock valued at $262,000 after purchasing an additional 34 shares during the last quarter. Midwest Capital Advisors LLC lifted its stake in shares of Intuitive Surgical by 81.7% in the 3rd quarter. Midwest Capital Advisors LLC now owns 189 shares of the medical equipment provider's stock valued at $77,000 after purchasing an additional 85 shares during the last quarter. Syntax Research Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $712,000. Fulcrum Asset Management LLP purchased a new stake in Intuitive Surgical in the 3rd quarter valued at about $2,368,000. Finally, Mizuho Securities Co. Ltd. acquired a new position in Intuitive Surgical in the third quarter valued at about $325,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the company an "overweight" rating in a research note on Wednesday, October 21st. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, October 31st. HSBC downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price target for the company. in a research note on Thursday, July 30th. Sanford C. Bernstein restated an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, Citigroup cut their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a research note on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $493.54.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Revenue grew 22%, and the company placed 546 da Vinci systems in the third quarter of 2026. The article notes that system placements support a larger installed base, while instruments and services generate much of Intuitive Surgical’s recurring revenue. Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street's Sell-Off Misses the Point.
• Positive Sentiment: Robust procedure growth and adoption of the da Vinci 5 system have helped shares recover, according to a six-month review. ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?
• Neutral Sentiment: Intuitive Surgical appeared on a published list of top healthcare stocks following the midterm elections. The inclusion reflects investor interest in the sector, but is not a company-specific business development. Why Intuitive Surgical (ISRG) Just Cracked the Top 10 Best Healthcare Stocks List
• Negative Sentiment: Growing competition, litigation costs and valuation concerns could weigh on the shares. One article also notes that ISRG remains down for the year despite strong revenue growth. Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?

Intuitive Surgical Stock Up 1.7%

Shares of ISRG opened at $460.56 on Tuesday. The company has a market capitalization of $159.65 billion, a price-to-earnings ratio of 55.69, a price-to-earnings-growth ratio of 3.32 and a beta of 1.45. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock has a 50 day moving average price of $411.69 and a 200 day moving average price of $431.58.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts' consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company's revenue was up 21.7% on a year-over-year basis. During the same period last year, the firm posted $2.40 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, VP Fredrik Widman sold 4,047 shares of the company's stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the sale, the vice president directly owned 1,026 shares of the company's stock, valued at $464,993.46. This represents a 79.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of the business's stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the sale, the director owned 1,150 shares of the company's stock, valued at approximately $529,000. This represents a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,056 shares of company stock valued at $17,585,864 over the last quarter. 0.60% of the stock is owned by corporate insiders.

About Intuitive Surgical

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.